Since one group studied for the first time the germline genetic polymorphisms in the PI3K-AKT-mTOR and cancer risk as well as clinical outcomes [19], [32], a number of studies have been performed to explore the possible influence of the genetic variants in this pathway genes on cancer development, progression, and prognosis. The gene discussed is MTOR; the disease is cancer.